China Immunoassay Market

ID: MRFR/HC/48533-HCR

200 Pages

Garvit Vyas

September 2025

China Immunoassay Market Research Report By Type (Enzyme-Linked Immunosorbent Assay, Radioimmunoassay, Fluorescent Immunoassay, Chemiluminescent Immunoassay, Western Blot), By Technology (Automated Immunoassay, Point of Care Immunoassay, Lateral Flow Assay), By Application (Clinical Diagnostics, Drug Development, Environmental Testing, Food Safety Testing) and By End Use (Hospitals, Diagnostic Laboratories, Pharmaceutical Companies, Academic Research Institutions) - Forecast to 2035

Single User

$ 4,950.0

Multiple License

$ 5,950.0

Enterprise User

$ 7,250.0

Summary Table of Contents Segmentation Infographic

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

China Immunoassay Market Summary

The China Immunoassay market is projected to grow from 348 million USD in 2024 to 585 million USD by 2035, reflecting a robust growth trajectory.

Key Market Trends & Highlights

China Immunoassay Key Trends and Highlights

The market is expected to reach 585 million USD by 2035, indicating a substantial increase from 348 million USD in 2024.
A compound annual growth rate (CAGR) of 4.84 percent is anticipated for the period from 2025 to 2035.
The growth in the market is likely driven by advancements in diagnostic technologies and increased healthcare spending.
Growing adoption of immunoassay technologies due to rising demand for accurate and rapid diagnostic solutions is a major market driver.

China Immunoassay Market

CAGR

4.84%

Market Size & Forecast

2024 Market Size	348 (USD Million)
2035 Market Size	585 (USD Million)
CAGR (2025-2035)	4.84%

Major Players

Merck Group, Beckman Coulter, Wondfo Biotech, Zhejiang Dian Diagnostic Technology, Hitachi HighTech, China National Pharmaceutical Group, Roche, Maccura Biotechnology, bioMérieux, Ortho Clinical Diagnostics, Danaher, Abbott, Siemens Healthineers, Thermo Fisher Scientific, Shenzhen Yhlo Biotech

China Immunoassay Market Trends

The China Immunoassay Market is witnessing several important trends that are shaping its landscape. One notable trend is the increasing prevalence of chronic diseases, which is driving a higher demand for diagnostic tests. The Chinese government has been focusing on improving healthcare access and quality, leading to a rise in immunoassay test adoption among hospitals and laboratories.

Moreover, technological advancements in immunoassay methods, such as the development of point-of-care testing, are enhancing testing efficiency and accuracy, making it easier for healthcare providers to deliver timely results. Key market drivers include the growing awareness of early disease detection and the need for personalized medicine. The population of China is focusing more on health, creating a need for efficient diagnostic tools.

Also, the government’s support towards innovation in medical technologies alongside funding in the biotechnological fields creates more reasons for market growth. There are possibilities to be seized like the widening use of immunoassays in new frontiers such as monitoring infectious diseases and environmental monitoring.

In the changing world of biotechnology, there is hope in advanced platforms of novel immunoassays that would be compatible with digital health systems. Also, current trends show a movement towards automation and incorporation of Artificial Intelligence into immunoassay systems, optimizing laboratory workflows and improving accuracy in diagnostics.

As the healthcare infrastructure in China evolves, collaborations between medical device manufacturers and research institutions are increasing, enhancing the research and development of more sophisticated immunoassay technologies. Collectively, these trends indicate a dynamic and rapidly evolving China Immunoassay Market, influenced by various factors that create the potential for sustained growth.

Market Segment Insights

Immunoassay Market Type Insights

The China Immunoassay Market, which is experiencing substantial growth, showcases a variety of types that each provide unique benefits for diagnostic purposes. A prominent type is the Enzyme-Linked Immunosorbent Assay, which is widely utilized due to its flexibility, cost-effectiveness, and ability to process multiple samples simultaneously, thus enhancing throughput in laboratories.

Following closely, Radioimmunoassay continues to hold significance, especially in research settings, as its sensitivity allows for the detection of minute quantities of analytes, making it invaluable in clinical diagnostics and research applications. Additionally, Fluorescent Immunoassay is gaining traction in China owing to the modern advancements in detection technologies, offering rapid results and high sensitivity, which is crucial in disease diagnosis and therapeutic monitoring.

One of the noteworthy types, Chemiluminescent Immunoassay, is appreciated for its very low detection limits and adaptability to automation, which aligns with the industry's movement toward high-throughput workflows. This type is particularly significant as it enables detailed laboratory work with patient samples, facilitating swift decision-making in clinical settings.

Lastly, Western Blot remains an important technique predominantly in confirming the presence of specific proteins, being essential in the identification and diagnosis of various infectious diseases and complex conditions. Collectively, these types within the China Immunoassay Market not only represent significant methodologies for medical diagnostics but also highlight ongoing advancements in technology and the implications of such advancements on healthcare delivery in China.

Market growth is driven by the increasing burden of chronic diseases and the growing focus on personalized medicine, which in turn augments the demand for sophisticated immunoassay technologies that cater to specific diagnostic needs across the country.

Immunoassay Market Technology Insights

The China Immunoassay Market, particularly within the Technology segment, is experiencing substantial growth driven by advancements in diagnostic technologies and increased healthcare expenditures. The market features key areas such as Automated Immunoassay, Point of Care Immunoassay, and Lateral Flow Assay, each contributing to the overall market dynamics.

Automated Immunoassay systems are gaining traction due to their efficiency and accuracy, facilitating high-throughput testing vital for clinical laboratories. On the other hand, Point of Care Immunoassay devices are pivotal for rapid diagnostics, especially in remote or underserved areas, significantly enhancing patient management and treatment timelines.

Lateral Flow Assays are widely utilized for their simplicity and user-friendliness, making them essential for home-based testing and disease outbreaks. The diverse application of these technologies underscores their importance in addressing public health needs in China, where the demand for effective diagnostic solutions is on the rise.

Furthermore, government initiatives aimed at expanding healthcare access are likely to influence the adoption and innovation of these immunoassay technologies positively. The combination of these factors positions the Technology segment as a crucial component of the China Immunoassay Market statistics, catering to the evolving demands of the healthcare sector.

Immunoassay Market Application Insights

The Application segment of the China Immunoassay Market plays a crucial role in driving market growth, reflecting various needs across multiple industries. Clinical Diagnostics is a key area, as it provides essential testing solutions for disease detection and management, thus enhancing patient outcomes.

The significance of Drug Development cannot be overstated, as it contributes to identifying and validating biomarkers, improving therapeutic efficacy, and ensuring safety in pharmaceutical products. Environmental Testing has gained traction in response to the increasing demand for pollution monitoring and compliance with regulatory standards, highlighting the necessity of accurate testing methods.

Meanwhile, Food Safety Testing remains vital due to heightened consumer awareness of foodborne illnesses and the necessity for stringent quality controls in the food supply chain. Each of these applications represents a significant driving force within the China Immunoassay Market, aligned with national health initiatives and regulatory frameworks, which further supports their expansion and relevance in contemporary society.

Immunoassay Market End Use Insights

The End Use segment of the China Immunoassay Market showcases a diverse range of applications playing a crucial role in healthcare and research. Hospitals represent a significant portion of this segment, driving demand for immunoassay tests to aid in disease diagnosis and management.

Diagnostic Laboratories play an equally vital role, as they are key providers of these tests, ensuring accuracy and quick results for patients. Furthermore, Pharmaceutical Companies utilize immunoassay techniques extensively in drug development and monitoring, highlighting their importance in ensuring drug effectiveness and safety.

Academic Research Institutions also contribute appreciably by using immunoassays for advanced research in various biomedical fields. Overall, the End Use segment is characterized by its critical contributions to patient care, pharmaceutical innovation, and scientific research, which collectively reflect the growing relevance of immunoassay technology in China’s healthcare landscape.

The continuous advancements in these areas foster market growth and capture significant attention from stakeholders aiming to leverage immunoassays for enhanced diagnostics and therapeutic solutions.

Get more detailed insights about China Immunoassay Market Research Report — Global Forecast till 2035

Request Free Sample

Key Players and Competitive Insights

The China Immunoassay Market is characterized by rapid growth and an increasingly competitive landscape, driven by advancements in technology, rising healthcare investments, and an expanding patient population. The market's dynamics are influenced by several players who are striving to enhance their product offerings, engage in strategic collaborations, and expand their geographical footprint.

Innovations in diagnostic testing processes and the increasing demand for point-of-care testing have further intensified competition among manufacturers. This burgeoning market is not only attracting established companies but also new entrants seeking to leverage pioneering technologies and comprehensive service solutions tailored to the specific demands of the Chinese healthcare system.

Merck Group

Merck Group has established a significant presence in the China Immunoassay Market, capitalizing on its extensive portfolio of products and services tailored for diagnostics and laboratory settings. The company's strengths lie in its commitment to innovation and quality, positioning it as a leader in immunoassay technologies.

Merck Group has made considerable investments in research and development, resulting in advanced assays and reagents that cater specifically to the diverse needs of the Chinese market. Their robust distribution network and strategic partnerships with local healthcare providers strengthen their market presence, thereby enhancing their ability to meet the growing demands for reliable diagnostic solutions across various clinical settings in China.

Beckman Coulter

Beckman Coulter also plays a vital role in the China Immunoassay Market through its comprehensive range of diagnostic products and services that are essential for patient management and healthcare decision-making. The company is recognized for its strong focus on automation and efficiency, providing high-quality immunoassay solutions that streamline laboratory workflows.

Key products include various immunoassay analyzers and assays that enable accurate disease detection and monitoring. Beckman Coulter's prowess in the market is bolstered by its ongoing investments in local research initiatives, which enhance product relevance to the specific needs of Chinese healthcare professionals.

The company has pursued strategic mergers and acquisitions to augment its capabilities and expand its market reach, thus further solidifying its competitive position within the rapidly evolving landscape of the China Immunoassay Market.

Key Companies in the China Immunoassay Market market include

Industry Developments

The China Immunoassay Market has witnessed significant developments recently, particularly with companies like Merck Group, Roche, and Abbott, which are continuously innovating their product portfolios to meet the growing demand for diagnostics. Notably, in December 2022, Hitachi High-Tech expanded its presence in China through an acquisition of a local diagnostic firm, enhancing its immunoassay capabilities.

A surge in investment has been noted, with Maccura Biotechnology receiving substantial funding in March 2023 to advance its Research and Development efforts in diagnostics technology. The market is also responding to increased healthcare expenditure, particularly in response to the COVID-19 pandemic, driving the need for rapid and reliable testing solutions.

Companies like Wondfo Biotech and Shenzhen Yhlo Biotech have been active in securing partnerships to enhance their market reach. With the ongoing advancements in technology, including automation and multiplex testing, the competition among manufacturers such as Siemens Healthineers and Thermo Fisher Scientific is intensifying.

Furthermore, the overall growth in China's healthcare sector has significantly raised the market valuation for immunoassay products, translating to increased accessibility and improved patient outcomes across the country.

Market Segmentation

Immunoassay Market Type Outlook

Enzyme-Linked Immunosorbent Assay
Radioimmunoassay
Fluorescent Immunoassay
Chemiluminescent Immunoassay
Western Blot

Immunoassay Market End Use Outlook

Hospitals
Diagnostic Laboratories
Pharmaceutical Companies
Academic Research Institutions

Immunoassay Market Technology Outlook

Automated Immunoassay
Point of Care Immunoassay
Lateral Flow Assay

Immunoassay Market Application Outlook

Clinical Diagnostics
Drug Development
Environmental Testing
Food Safety Testing

Report Scope

Report Attribute/Metric	Details
Market Size 2023	334.5 (USD Million)
Market Size 2024	348.0 (USD Million)
Market Size 2035	585.0 (USD Million)
Compound Annual Growth Rate (CAGR)	4.835% (2025 - 2035)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Million
Key Companies Profiled	Santen Pharmaceutical, Emergen Vision, VisionCare, Ocular Therapeutix, EyeKon Medical, Johnson & Johnson, Alcon, Abbott Laboratories, HumanOptics, Rayner, Bausch Health, Kowa Company, Hoya Corporation, Carl Zeiss, Lumenis
Segments Covered	Product Type, Material Type, Surgery Type, End Use
Key Market Opportunities	Rising aging population demand, Increased prevalence of cataracts, Advances in lens technology, Growing eye care awareness, Government healthcare initiatives support
Key Market Dynamics	Aging population, increasing cataract surgeries, technological advancements, rising healthcare expenditure, and growing awareness of eye health
Countries Covered	China

China Immunoassay Market Research Report — Global Forecast till 2035 Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Stories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne Founder

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027